SANCILIO PHARMACEUTICALS COMPANY, INC. Trademark

Trademark Overview

On Monday, August 24, 2015, a trademark application was filed for SANCILIO PHARMACEUTICALS COMPANY, INC. with the United States Patent and Trademark Office. The USPTO has given the SANCILIO PHARMACEUTICALS COMPANY, INC. trademark a serial number of 86735268. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 10, 2024. This trademark is owned by Sancilio Pharmaceuticals Company, Inc.. The SANCILIO PHARMACEUTICALS COMPANY, INC. trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention of various human disorders, namely, sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders; Pharmaceutical preparations for the treatment and prevention of various human disorders, namely, sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders; Pharmaceutical preparations for the treatment of various human disorders, namely, sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders
sancilio pharmaceuticals company, inc.

General Information

Serial Number86735268
Word MarkSANCILIO PHARMACEUTICALS COMPANY, INC.
Filing DateMonday, August 24, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 10, 2024
Registration Number5314532
Registration DateTuesday, October 24, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2017

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention of various human disorders, namely, sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders; Pharmaceutical preparations for the treatment and prevention of various human disorders, namely, sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders; Pharmaceutical preparations for the treatment of various human disorders, namely, sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders
Section 2(f) Limitation Statementas to "SANCILIO"
NOT AVAILABLE"PHARMACEUTICALS COMPANY, INC."

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 10, 2024
Primary Code005
First Use Anywhere DateThursday, February 16, 2017
First Use In Commerce DateThursday, February 16, 2017

Trademark Owner History

Party NameGENERX, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDOVER, DE 19901
Party NameMICELLE BIOPHARMA, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRIVIERA BEACH, FL 33404
Party NameSancilio Pharmaceuticals Company, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRiviera Beach, FL 33404
Party NameSancilio Pharmaceuticals Company, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRiviera Beach, FL 33404
Party NameSancilio Pharmaceuticals Company, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRiviera Beach, FL 33404

Trademark Events

Event DateEvent Description
Thursday, August 27, 2015NEW APPLICATION ENTERED
Thursday, August 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 7, 2015ASSIGNED TO EXAMINER
Thursday, December 10, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 10, 2015NON-FINAL ACTION E-MAILED
Thursday, December 10, 2015NON-FINAL ACTION WRITTEN
Wednesday, June 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 8, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 8, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 28, 2016NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 28, 2016NON-FINAL ACTION E-MAILED
Thursday, June 30, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 6, 2016ASSIGNED TO LIE
Wednesday, July 13, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 18, 2016NON-FINAL ACTION WRITTEN
Monday, July 25, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 9, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Sunday, August 14, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, August 18, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 18, 2016NON-FINAL ACTION E-MAILED
Friday, February 17, 2017TEAS AMENDMENT OF USE RECEIVED
Saturday, February 18, 2017USE AMENDMENT FILED
Friday, February 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 18, 2017AMENDMENT TO USE PROCESSING COMPLETE
Saturday, February 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2017NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 7, 2017USE AMENDMENT ACCEPTED
Tuesday, August 8, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 8, 2017FINAL REFUSAL WRITTEN
Wednesday, March 8, 2017FINAL REFUSAL E-MAILED
Wednesday, March 8, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 9, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 24, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 11, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 24, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 10, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

company pharmaceuticals sancilio disorders sickle cell disease namely human preparations pharmaceutical various short